The shareholders of Cellectis (ENXTPA:ALCLS) authorized a share repurchase program at its Combined General Shareholders' Meeting on June 14, 2013. Under the program, the company will repurchase its own shares.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.835 EUR | +0.53% | +2.72% | +2.57% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.57% | 218M | |
+19.41% | 47.02B | |
+48.77% | 41.86B | |
+0.19% | 41.76B | |
-4.27% | 28.8B | |
+11.71% | 26.05B | |
-22.06% | 19.15B | |
+4.48% | 12.55B | |
+29.23% | 12.34B | |
-3.90% | 11.82B |
- Stock Market
- Equities
- ALCLS Stock
- News Cellectis S.A.
- Cellectis announces an Equity Buyback.